Evidence mapPaperPMID 35893239Full record

ArticleNon-coding RNA2022

Systematic Analysis of Long Non-Coding RNA Genes in Nonalcoholic Fatty Liver Disease.

Mirolyuba Ilieva, James Dao, Henry E Miller, Jens Hedelund Madsen, Alexander J R Bishop, Sakari Kauppinen, Shizuka Uchida

Open access · goldAbstract read
In one paragraph

Article in Non-coding RNA, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed, 1 pooled it
1.5field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 1 synthesis or guideline pooled it, 17 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Methods and Tools in RNA Biology.Non-coding RNA · 2023
    Article
  9. Article
  10. Article
  11. Article
  12. Long Noncoding RNAs in the Pathogenesis of Insulin Resistance.International journal of molecular sciences · 2022
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 2 countries.

Mirolyuba IlievaCenter for RNA Medicine, Department of Clinical Medicine, Aalborg University, DK-2450 Copenhagen SV, Denmark.ORCID 0000-0002-7992-8885
James DaoBioinformatics Research Network, Atlanta, GA 30317, USA.ORCID 0000-0003-2596-9531
Henry E MillerBioinformatics Research Network, Atlanta, GA 30317, USA.ORCID 0000-0003-3756-3918
Jens Hedelund MadsenCenter for RNA Medicine, Department of Clinical Medicine, Aalborg University, DK-2450 Copenhagen SV, Denmark.
Alexander J R BishopDepartment of Cell Systems and Anatomy, UT Health San Antonio, San Antonio, TX 78229, USA.ORCID 0000-0002-5742-4387
Sakari KauppinenCenter for RNA Medicine, Department of Clinical Medicine, Aalborg University, DK-2450 Copenhagen SV, Denmark.
Shizuka UchidaCenter for RNA Medicine, Department of Clinical Medicine, Aalborg University, DK-2450 Copenhagen SV, Denmark.ORCID 0000-0003-4787-8067
Aalborg University · DKResearch Network (United States) · USThe University of Texas Health Science Center at San Antonio · US

Funding

Dysregulated transcription processes in Ewing sarcomaR01CA241554 · RESEARCH INST NATIONWIDE CHILDREN'S HOSP · 2025 to 2025
$291k
NCI NIH HHS R01 CA241554NIA NIH HHS F31 AG072902NIH HHS 1R01CA241554NIH HHS F31AG072902Novo Nordisk Foundation NNF18OC0033438Stand Up to Cancer-Cancer Research UK RT6187
6 · The paper itself

Abstract

The largest solid organ in humans, the liver, performs a variety of functions to sustain life. When damaged, cells in the liver can regenerate themselves to maintain normal liver physiology. However, some damage is beyond repair, which necessitates liver transplantation. Increasing rates of obesity, Western diets (i.e., rich in processed carbohydrates and saturated fats), and cardiometabolic diseases are interlinked to liver diseases, including non-alcoholic fatty liver disease (NAFLD), which is a collective term to describe the excess accumulation of fat in the liver of people who drink little to no alcohol. Alarmingly, the prevalence of NAFLD extends to 25% of the world population, which calls for the urgent need to understand the disease mechanism of NAFLD. Here, we performed secondary analyses of published RNA sequencing (RNA-seq) data of NAFLD patients compared to healthy and obese individuals to identify long non-coding RNAs (lncRNAs) that may underly the disease mechanism of NAFLD. Similar to protein-coding genes, many lncRNAs are dysregulated in NAFLD patients compared to healthy and obese individuals, suggesting that understanding the functions of dysregulated lncRNAs may shed light on the pathology of NAFLD. To demonstrate the functional importance of lncRNAs in the liver, loss-of-function experiments were performed for one NAFLD-related lncRNA,

Indexed as

gene expressionliverlncRNANAFLDNASHRNA-seq

Identifiers

PMID35893239
PMCPMC9332188
OpenAlexW4287149059

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.